Results 241 to 250 of about 15,380,906 (402)

A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development.

open access: yesJournal of Infectious Diseases, 2014
M. Sanderson-Smith   +17 more
semanticscholar   +1 more source

Molecular Diagnostics of Neurofibromatosis Type 1

open access: yesPeriodicum biologorum, 1998
Neurofibromatosis type 1 (NF1), also called von recklinghausen disease or peripheral neurofibromatosis, is a common autosomal dominant disorder characterized by multiple neurofibromas, cafe au lait spots and Lisch nodules of the iris, with a variable clinical expression.
openaire   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Molecular Typing of Tick-Borne Pathogens in Ixodids of Bosnia and Herzegovina. [PDF]

open access: yesMicroorganisms
Hoxha I   +9 more
europepmc   +1 more source

Multi-locus sequence typing: A useful tool for trachoma molecular epidemiology. [PDF]

open access: yes, 2010
Andreasen, A   +10 more
core  

Improved Molecular Typing Assay for Rhinovirus Species A, B, and C

open access: yesJournal of Clinical Microbiology, 2014
Y. Bochkov   +4 more
semanticscholar   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy